Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab
Status: UNKNOWN
Study type: OBSERVATIONAL
Conditions: HER2-positive Metastatic Breast Cancer|Previously Treated With Trastuzumab|Trastuzumab Combined With Pertuzumab and Chemotherapy
Interventions: DRUG: trastuzumab(Henlius®) combined with Pertuzumab(Perjeta®) and Chemotherapy
Sponsor: Peking University Cancer Hospital & Institute